Cantourage Group SE Logo

Cantourage Group SE

ISIN: DE000A3DSV01 | Ticker: HIGH

About Cantourage Group SE

Company Description

Cantourage is a publicly listed, leading European medical cannabis company. The Berlin-based company with subsidiaries in the United Kingdom and Poland, was founded in 2019 by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffmann. Cantourage enables producers from all over the world to become part of the rapidly growing European medical cannabis market in a faster and more cost-effective way, while guaranteeing and developing the highest European quality standards. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol. The company was listed on the Frankfurt Stock Exchange on 11 November 2022 and is listed under the stock ticker “HIGH”.

Year founded

2019

Served area

Europe

Headquarters

Feurigstraße 54, 10827 Berlin – Germany

Shareholder information

Shares outstanding

11,880,000

IPO

Jan. 1, 2019

Stock exchange(s)

Borsa Italiana

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.